Uncovering the Impact of DRG Downgrades and Post-Pay Audits on Hospital Margins

Diagnosis-related group (DRG) downgrades are surging as one of the top payer denials tactics, increasing nearly 57% between 2022 and 2023. No longer just occasional frustrations, these downgrades—along with post-pay audits—quietly erode revenue while avoiding traditional reporting measures.

As hospital revenue management enters a period of rapid transformation, payer denials are growing more sophisticated and require relentless vigilance and innovation. The ability to turn administrative hurdles into opportunities for financial success and operational excellence is becoming essential for healthcare organizations committed to sustaining quality patient care.

The New Face of Denials

Erica Strick, vice president of denials management services at CorroHealth, succinctly captures the tone of today’s environment: “DRG downgrades are becoming more automatic.” High-volume DRG downgrades and post-pay programs are increasingly driving what once required a thoughtful review of medical records and clinical nuance. This shift is not merely theoretical. A recent denials management webinar drew nearly 200 advance questions from participants, demonstrating how deeply this issue now shapes day-to-day operations.

Crucially, the source of the problem has changed. As mentioned in the webinar, over 90% of downgrades arise from clinical validation disputes, not coding errors, which is a dramatic change in recent years. Payers are no longer questioning whether the right code was applied. Instead, they are challenging whether the documented diagnoses are valid and supported. For hospitals and health systems, that means downgrades are as much about clinical criteria and documentation as they are about coding mechanics.

Moreover, with —and some payers engaging several firms for a single claims population—the landscape is undeniably complex.

Evolving Dynamics of Post-Pay Audits

Post-pay audits are particularly elusive. Organizations often believe these claims are fully resolved—accounts are closed, payments received, and balances cleared. Yet months or even years later, these same claims resurface as retroactive audits, recoupments, or corrections. As many DRG downgrades are not clearly reflected on 835 electronic remittance advice (ERA) files and often lack transparent denials codes, these adjustments can quietly slip into routine audit recoveries. Hidden patterns within these adjustments must be mined to flag potential downgrades and guide targeted chart reviews where the impact matters most.

Without focused scrutiny, post-pay audits secretly erode margins—fueling the disconnect between apparently strong paid rates and unexplained revenue shortfalls. Forward-thinking organizations seeking clarity should invest in structured tracking, cross-functional review, and proactive data analysis to both identify and address post-pay risk before it undermines the bottom line.

Volume as a Strategy

DRG downgrades and post-pay audits are not just high stakes. As Strick noted, “It’s a lot of work with a lot of volume,” adding that “hospitals can’t keep up while still writing very detailed supported appeal letters” for downgrades. That imbalance is not accidental. Payers know that when they turn up the volume, they put pressure on provider capacity. If a hospital cannot keep pace, downgrades naturally slip through and become de facto write-offs—costing the health care system billions of dollars, on average.

This aspect is where disciplined denials management separates reactive organizations from strategic ones. The most successful programs accept that volume is part of the game and respond with structured classification, objective appeal criteria, and multidisciplinary teams. They do not try to treat every case as equally important. Instead, they focus on the downgrades that matter most while still maintaining a consistent, principled posture across the board.

Appeal to What Matters

Organizational stance becomes critical. “Unless it is a coding error or something that is simply not supported… we appeal everything,” Strick said, emphasizing the need for a disciplined approach. The message is that not every single case needs a detailed appeal, but defensible DRG downgrades should be actively challenged. They should be systematically surfaced, evaluated, and, when appropriate, strategically appealed.

When this kind of prioritization and discipline is applied, results follow. Case in point: a leading hospital that prioritized its denials management achieved a sustained 50% reduction in outpatient technical denials, freeing up staff capacity and protecting revenue that would have otherwise been written off. The same principles can be extended to post-pay audits—define what to contest, design workflows that support this strategy, and leverage data.

Contracts as a Primary Line of Defense

Over time, a strategic denials program does more than respond. It reshapes the rules of engagement. “The biggest recommendation that we have been really pushing on our hospital systems is contract negotiations,” Strick emphasized. When operational back-and-forth is limited to DRG downgrades and post‑pay audits, payers retain considerable leverage in how and when payments are reduced. Contracts that clearly define audit scope, clinical criteria, timeframes, documentation expectations, and dispute processes help rebalance that dynamic.

Hospitals and health systems are increasingly using downgrade and appeal data to inform these conversations. They provide solid proof of patterns, like repeated downgrades for certain DRGs or diagnoses, and use that information to push for clearer and more fair language. The goal is not to eliminate oversight but to ensure that oversight operates within transparent, mutually understood parameters. Once those terms are in place, every appeal can draw not only on clinical and coding evidence but also on contractual commitments.

From Silos to Synergy

The organizations that are making the most progress with hidden denials are not necessarily those with the largest teams. They are the ones that break down silos and treat denials, including post-pay audits, as a cross-functional challenge. In organizations that eliminate silos and combine advanced data analytics with streamlined workflows, the outcomes can be remarkable. One health system, for instance, saw a 600% rise in overturned denials following the implementation of focused reporting and workflow enhancements.

That kind of improvement does not come from technology alone. It comes from aligning CDI, coding, utilization review, revenue integrity, and denials teams around shared definitions, shared data, and shared priorities. DRG downgrades and post-pay outcomes become a feedback loop into documentation education, clinical criteria alignment, and contract strategy. The same insights that overturn a downgrade today help prevent the next one or strengthen the organization’s footing when it is challenged again.

Turning Complexity into Strategic Insight

DRG downgrades and post-pay audits are not going away. They are a natural extension of payer strategies built on data, algorithms, and retrospective leverage. But they do not have to remain hidden. Hospitals and health systems that succeed in this environment will be those that treat these downgrades as a distinct denial category, analyze data for trends, enforce a disciplined appeals process, strategically use contracts, and align all teams for a coordinated response.

When that happens, the story of DRG downgrades changes. Instead of just being a frustrating and unclear loss of revenue, DRG downgrades turn into valuable information about how payers act, how well the hospital is performing, and how clinical practices match up with payments. In a world where denials pressure is only increasing, using that insight well is how hospitals and health systems transform hidden impact into financial resilience and continued investment in patient care.